![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at 27th Annual ROTH Conference
March 06, 2015 09:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., March 6, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the 27th Annual ROTH Conference at 12:30 p.m....
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Observes Rare Disease Day 2015
February 27, 2015 08:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today joins with patients and their families, caregivers, researchers, the biopharmaceutical industry and...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results
February 26, 2015 16:05 ET
|
Hyperion Therapeutics, Inc.
UCD Product Portfolio Generates $113.6 Million for Fiscal Year 2014 and $30.8 Million in Net Sales During the Fourth Quarter of 2014
-- Company Generates $31 Million in Operating Cash Flows in...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference
February 25, 2015 16:45 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Cowen and Company 35th Annual Health Care...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results After Market on February 26, 2015
February 19, 2015 16:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report fourth quarter and full year 2014 financial results after market...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Enters Into Completion of Phase III Clinical Trial, Option and Mutual Release Agreement With Clal Biotechnology Industries and Yeda Research and Development Company
February 17, 2015 01:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) ("Hyperion") today announced that it has amicably resolved its disputes, and entered into a completion of...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Initiates Clinical Study to Further Evaluate RAVICTI(R) in Pediatric Subjects Under Two Years of Age With Urea Cycle Disorders
February 10, 2015 09:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced the dosing of the first patient in its HPN-100-009 study in pediatric subjects under two...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics to Present at the 2015 Leerink Global Healthcare Conference
February 04, 2015 16:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the 2015 Leerink Global Healthcare Conference...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Announces Data Published in Genetics in Medicine Showing Blood Ammonia and Glutamine as Predictors of Hyperammonemic Crises in Patients With Urea Cycle Disorders
January 12, 2015 09:25 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced the online publication in Genetics in Medicine of analyses from four short-term switchover...
![Hyperion Logo](/news-release/logo/302957/0/302957.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A06&size=2)
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI)
December 18, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index®...